(via TheNewswire)

January 8, 2026 – TheNewswire - Vancouver, British Columbia, Canada – Neurothera Labs Inc. (TSXV: NTLX) (“ Neurothera ” or the “ Company ”), a clinical-stage biotech company and a majority-owned subsidiary of SciSparc Ltd. (Nasdaq: SPRC), is pleased to announce the results of its annual and special meeting of shareholders (“ AGM ”) held today.

All of the nominee directors listed in Neurothera’s management information circular dated December 4, 2025 (the “ Circular ”) were elected as directors. Furthermore, shareholders of the Company voted in favour of appointing Dale Matheson Carr-Hilton Labonte LLP as auditors of the Company for the ensuing year and authorizing the directors to fix their remuneration.

Shareholders of the Company also voted in favour of authorizing the Company to effect a consolidation of the common shares of the Company (“ Common Shares ”) on the basis of one post-consolidation Common Share for up to one hundred (100) pre-consolidation Common Shares, as determined by the directors of the Company, in their sole discretion. For greater certainty and notwithstanding the foregoing, the directors of the Company have not yet determined to effect the consolidation and may elect not to proceed with the consolidation, in their sole discretion (subject to fiduciary and statutory duties). The directors will continue to assess market conditions and the interests of the Company and shareholders before proceeding to effect the consolidation, if at all. To be effective, the consolidation must also be approved by the TSX Venture Exchange.

Lastly, shareholders of the Company approved by ordinary resolution the adoption of the 20% fixed equity incentive plan (the “ Equity Incentive Plan ”), as further described in the Circular. Adoption of the Equity Incentive Plan is subject to final TSX Venture Exchange approval.

About Neurothera Labs Inc.

Neurothera Labs Inc. (TSXV: NTLX) is a clinical-stage pharmaceutical company focused on developing novel therapeutics for central nervous system disorders and other underserved health conditions through collaborations and innovative combinations.

For further information, please contact:

Michal Efraty IR Manager

Neurothera Labs Inc.

Telephone: +972-3-7617108

Email: michal@efraty.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Information

This press release contains “forward-looking statements” within the meaning of the securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. Forward-looking statements are not historical facts, and are based upon management’s current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management’s expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company’s reports filed from time to time at sedarplus.ca. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. The Company is not responsible for the contents of third-party websites.

Copyright (c) 2026 TheNewswire - All rights reserved.